Ads
related to: trelegy for asthma
Search results
A Life-long Asthma Patient Shares How She’s Learned to Manage Her Condition
Parade via Yahoo News· 11 months agoRashelle Stocker was diagnosed with asthma in third grade after having her first attack on the...
Theravance Biopharma (TBPH) to Sell Trelegy Royalty Interests
Zacks via Yahoo Finance· 2 years agoTheravance Biopharma (TBPH) agrees to sell its Trelegy royalty interests to Royalty Pharma. The...
These Inhalers No Longer Cost More Than $35 Per Month
Verywell Health via Yahoo News· 3 weeks agoGrace Cary / Getty Images Fact checked by Nick Blackmer Key Takeaways Three major pharmaceutical...
GSK to cap out-of-pocket inhaler costs in US
Reuters via Yahoo News· 1 month agoThe cost cap would apply to all of its asthma and chronic obstructive pulmonary disease (COPD) medicines, including Advair Diskus, Advair HFA, and...
See price hikes for top 25 drugs covered by Medicare; NJ drugmakers sue to stop change
App.com | Asbury Park Press via Yahoo Finance· 8 months agoAverage prices for 25 widely used drugs covered by Medicare more than tripled since they were...
Royalty Pharma plc (RPRX) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoThank you for joining us to review Royalty Pharma's second quarter 2022 results. All forward-looking...
GSK's Key Drugs to Drive Sales in a Sluggish Second Half
Zacks via Yahoo Finance· 2 years agoGSK's specialty products like Dovato, Nucala, Trelegy Ellipta, Shingrix are driving sales, making up...
Amazon Pharmacy now automatically applies coupons on select brand name drugs
TechCrunch· 1 year agoAmazon Pharmacy announced today that it will now automatically apply manufacturer coupons on brand...
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
Zacks via Yahoo Finance· 4 weeks agoGSK plc (GSK) plans to lower the prices of its entire inhaled respiratory products to $35 per month...
Theravance (TBPH) Q3 Loss Narrower Than Expected, Sales Miss
Zacks via Yahoo Finance· 1 year agoTheravance Biopharma, Inc. TBPH reported third-quarter 2022 net loss of 21 cents per share, narrower...
Ads
related to: trelegy for asthma